EMEA-003605-PIP01-24 - paediatric investigation plan
alvelestat
PIPHuman
Key facts
- Active Substance
- alvelestat
- Therapeutic area
- Congenital, familial and genetic disorders
- Decision number
- P/0258/2024
- PIP number
- EMEA-003605-PIP01-24
- Pharmaceutical form(s)
- Film-coated tablet
- Condition(s) / indication(s)
- Treatment of congenital alpha-1 antitrypsin deficiency
- Route(s) of administration
- Oral use
- Contact for public enquiries
Mereo Biopharma Ireland Limited
E-mail: paediatrics@mereobiopharma.com
Tel.: +1 6509958341- Decision type
- W: decision granting a waiver in all age groups for all conditions or indications
- Decision date